ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,591.30
      -0.76%
      US Tech 100
      19,845.80
      -1.35%
      Dow Jones
      39,802.71
      0.20%
      Brent Oil
      84.955
      -0.11%
      Bitcoin
      57,856.32
      0.17%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aclaris Therapeutics Inc (ACRS)

      7. Aclaris Therapeutics Inc (ACRS) News

      ACRS

      Aclaris Therapeutics (ACRS)

      Aclaris Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ACRS
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      12/21/20212:11AMTipRanksH.C. Wainwright Reaffirms Their Buy Rating on Aclaris Therapeutics (ACRS)NASDAQ:ACRSAclaris Therapeutics Inc
      12/09/20212:38AMTipRanksLeerink Partners Reiterates a Buy Rating on Aclaris Therapeutics (ACRS)NASDAQ:ACRSAclaris Therapeutics Inc
      12/07/20217:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      12/03/20214:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/03/20217:00AMGlobeNewswire Inc.Aclaris Therapeutics Announces Publication of Preclinical Research of Zunsemetinib in Pancreatic Cancer in Science Translational MedicineNASDAQ:ACRSAclaris Therapeutics Inc
      11/18/20214:01PMGlobeNewswire Inc.Aclaris Therapeutics to Host Virtual R&D Day on December 7, 2021NASDAQ:ACRSAclaris Therapeutics Inc
      11/03/20214:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      11/03/20217:00AMGlobeNewswire Inc.Aclaris Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:ACRSAclaris Therapeutics Inc
      11/02/20217:33AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRSAclaris Therapeutics Inc
      11/02/20217:17AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      11/02/20217:00AMGlobeNewswire Inc.Aclaris Therapeutics Reports Third Quarter 2021 Financial Results and Provides a Corporate UpdateNASDAQ:ACRSAclaris Therapeutics Inc
      09/02/20215:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      08/27/20214:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      08/27/20214:01PMGlobeNewswire Inc.Aclaris Therapeutics Announces Proposed Settlement and Settlement Hearing of Stockholder Derivative ActionNASDAQ:ACRSAclaris Therapeutics Inc
      08/26/20214:01PMGlobeNewswire Inc.Aclaris Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:ACRSAclaris Therapeutics Inc
      08/05/20217:32AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRSAclaris Therapeutics Inc
      08/05/20217:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      08/05/20217:00AMGlobeNewswire Inc.Aclaris Therapeutics Reports Second Quarter 2021 Financial Results and Provides a Corporate UpdateNASDAQ:ACRSAclaris Therapeutics Inc
      07/26/20214:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      07/08/20217:00AMGlobeNewswire Inc.Aclaris Therapeutics to Participate in the William Blair Biotech Focus Conference 2021NASDAQ:ACRSAclaris Therapeutics Inc
      07/07/20216:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      06/11/20214:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      06/10/20214:26PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACRSAclaris Therapeutics Inc
      06/09/20217:55PMGlobeNewswire Inc.Aclaris Announces Pricing of Public Offering of Common StockNASDAQ:ACRSAclaris Therapeutics Inc
      06/08/20214:26PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACRSAclaris Therapeutics Inc
      06/08/20214:15PMGlobeNewswire Inc.Aclaris Announces Proposed Public Offering of Common StockNASDAQ:ACRSAclaris Therapeutics Inc
      06/08/20217:17AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      06/08/20217:00AMGlobeNewswire Inc.Aclaris Therapeutics Announces Positive Preliminary Topline Data from Phase 2a Trial of ATI-1777 for Moderate to Severe Atopi...NASDAQ:ACRSAclaris Therapeutics Inc
      06/04/20217:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ACRS

      Your Recent History

      BIT
      SXBK7L
      Sg Issuer
      BIT
      UC4CUM
      Unicredit Bank
      Delayed Upgrade Clock